MedComm – Future Medicine

Overview

Aim of the journal

MedComm – Future Medicine is a peer-reviewed open access journal that publishes high quality research in medicine and biology on the basis of novelty, timeliness and significance to human health and diseases. It covers the latest advances in biomedical research and healthcare delivery that will address unmet medical needs and transform future medical therapies. These include demonstration of technological innovations (including screening, diagnosis, prevention and treatment) and novel interventions for human diseases with potential for future clinical translation.

Scope and topics

MedComm – Future Medicine is a multidisciplinary journal covering topics of interest, including multiomics, bioinformatics, medical artificial intelligence (AI), stem cell and regenerative medicine, gene editing and therapy, relating to major human health and diseases, including but not limited to cancer, cardiovascular diseases, autoimmune diseases, nervous system diseases, and aging.

MedComm – Future Medicine focuses on the discovery of novel disease mechanisms and application of cutting-edge technologies to meet medical challenges. Relevant topics include, but are not limited to, development of ground-breaking technologies and therapies, interdisciplinary approaches, application of big data and AI in healthcare delivery, and precision medicine for early detection and outcome prediction for major diseases.

Indexing information:

• CAS: Chemical Abstracts Service (ACS)
• Directory of Open Access Journals (DOAJ)
• SCOPUS (Elsevier)